{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:35:34Z","timestamp":1794274534209,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.diabres.2025.113001","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:19:36Z","timestamp":1763630376000},"page":"113001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Global guideline recommended target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes: An updated meta-analysis of 1,618,972 participants"],"prefix":"10.1016","volume":"230","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8908-5905","authenticated-orcid":false,"given":"Ghanshyam","family":"Kacha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Highton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7473-5999","authenticated-orcid":false,"given":"Mark P.","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8417-9700","authenticated-orcid":false,"given":"Clare","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-4925","authenticated-orcid":false,"given":"Tolu","family":"Onuwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1843-0028","authenticated-orcid":false,"given":"Niraj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Cos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.113001_b0005","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"109119","author":"Sun","year":"2022","journal-title":"Diabet Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.113001_b0010","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"15","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.113001_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"7258","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.diabres.2025.113001_b0020","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"2022","author":"Davies","year":"2022","journal-title":"Diabet Care"},{"key":"10.1016\/j.diabres.2025.113001_b0025","first-page":"703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"7160","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2025.113001_b0030","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"24","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2025.113001_b0035","first-page":"1575","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"17","author":"ACCORD Study Group","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.113001_b0040","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee. 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes\u20142024. Diabetes Care, 2023;Supplement_1:S179\u2013S218.","DOI":"10.2337\/dc24-S010"},{"key":"10.1016\/j.diabres.2025.113001_b0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"2","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2025.113001_b0050","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/HYPERTENSIONAHA.116.08076","article-title":"Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood pressure intervention Trial) ambulatory blood pressure study","volume":"1","author":"Drawz","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.diabres.2025.113001_b0055","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.3390\/jcm12237432","article-title":"Evolution of more aggressive LDL-cholesterol targets and therapies for cardiovascular disease prevention","volume":"23","author":"Jones","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabres.2025.113001_b0060","first-page":"117","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"9607","author":"Kearney","year":"2008","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.diabres.2025.113001_b0065","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jacc.2019.06.043","article-title":"Reduction in first and total ischemic events with icosapent ethyl across baseline triglyceride tertiles","volume":"8","author":"Bhatt","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2025.113001_b0070","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"22","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.113001_b0075","first-page":"1337","article-title":"Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: time to overcome multifactorial therapeutic inertia?","volume":"6","author":"Khunti","year":"2018","journal-title":"DiabetesObes Metab"},{"key":"10.1016\/j.diabres.2025.113001_b0080","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988\u20132010","volume":"8","author":"Stark Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.113001_b0085","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","article-title":"Trends in diabetes treatment and control in US adults, 1999\u20132018","volume":"23","author":"Fang","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2025.113001_b0090","article-title":"Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: a meta-analysis","volume":"137\u2013148","author":"Khunti","year":"2018","journal-title":"Diabet ResClin Pract"},{"key":"10.1016\/j.diabres.2025.113001_b0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"7414","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.diabres.2025.113001_b0100","first-page":"1","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","author":"Barker","year":"2021","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.diabres.2025.113001_b0105","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dc12-1759","article-title":"Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study","volume":"9","author":"Stone","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.113001_b0110","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/02813432.2018.1459238","article-title":"Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014","volume":"2","author":"Tran","year":"2018","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.diabres.2025.113001_b0115","article-title":"Glycaemic monitoring and control among high-risk patients with type 2 diabetes in Australian general practice during COVID-19","volume":"3","author":"Barlow","year":"2023","journal-title":"Fam Med Commun Health"},{"key":"10.1016\/j.diabres.2025.113001_b0120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/TCRM.S182716","article-title":"Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings","author":"Elnaem","year":"2019","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.diabres.2025.113001_b0125","article-title":"Real-world evaluation of care for type 2 diabetes in Malaysia: a cross-sectional analysis of the treatment adherence to guideline evaluation in type 2 diabetes (TARGET-T2D) study","volume":"1","author":"Lim","year":"2024","journal-title":"PLoS one"},{"key":"10.1016\/j.diabres.2025.113001_b0130","doi-asserted-by":"crossref","unstructured":"Mata-Cases, M, Vlacho, B, Real, J, Puig-Treserra, R, Bund\u00f3, M, Franch-Nadal, J et al. Trends in the degree of control and treatment of cardiovascular risk factors in people with type 2 diabetes in a primary care setting in Catalonia during 2007\u20132018. Front Endocrinol 2022:810757.","DOI":"10.3389\/fendo.2021.810757"},{"key":"10.1016\/j.diabres.2025.113001_b0135","first-page":"29","article-title":"GALIPDIA study: reaching lipid targets in a population with type 2 diabetes (T2DM) from the Northwest of Spain","volume":"1","author":"Villar-Taibo","year":"2023","journal-title":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed)"},{"key":"10.1016\/j.diabres.2025.113001_b0140","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12875-022-01889-3","article-title":"Mode of treatments and achievement of treatment targets among type 2 diabetes patients with different comorbidities\u2013a register-based retrospective cohort study in Finland","volume":"1","author":"Nazu","year":"2022","journal-title":"BMC Primary Care"},{"key":"10.1016\/j.diabres.2025.113001_b0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41387-018-0028-y","article-title":"Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors","volume":"1","author":"Gant","year":"2018","journal-title":"Nutr Diabetes"},{"key":"10.1016\/j.diabres.2025.113001_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1138956","article-title":"Adherence to the therapeutic guidelines recommendations among the people with type 2 diabetes mellitus and obesity, frailty, or recent diagnosis, attended in primary health care centers in Spain: a cross-sectional study","author":"Vlacho","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.diabres.2025.113001_b0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.3390\/diagnostics12040814","article-title":"Compliance with cardiovascular prevention guidelines in type 2 diabetes individuals in a middle-income region: a cross-sectional analysis","volume":"4","author":"Barreto","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.diabres.2025.113001_b0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12882-021-02394-y","article-title":"Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations\u2013a registry-based analysis","volume":"1","author":"Bramlage","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diabres.2025.113001_b0165","article-title":"Achievement of the ESC recommendations for secondary prevention of cardiovascular risk factors in high-risk patients with type 2 diabetes: a real-world national cohort analysis","volume":"104\u2013111","author":"Salem","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2025.113001_b0170","article-title":"Type 2 diabetes disease and management patterns across a large, diverse healthcare system: issues and opportunities for guideline-directed therapies","volume":"114\u2013124","author":"Blood","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabres.2025.113001_b0175","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S2213-8587(23)00159-6","article-title":"Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes","volume":"11","author":"Leslie","year":"2023","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/j.diabres.2025.113001_b0180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2337\/db24-0166","article-title":"When does metabolic memory start? insights from the association of medical diabetologists annals initiative on stringent HbA1c targets","volume":"1","author":"Russo","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2025.113001_b0185","article-title":"Management of LDL\u2010cholesterol levels in patients with Diabetes Mellitus in cardiology practice: real\u2010life evidence of Under\u2010treatment from the EPHESUS registry","volume":"7","author":"Mert","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diabres.2025.113001_b0190","first-page":"1","article-title":"Improving statin treatment strategies to reduce LDL-cholesterol: factors associated with targets\u2019 attainment in subjects with and without type 2 diabetes","author":"Morieri","year":"2021","journal-title":"Cardiovascular Diabetol"},{"key":"10.1016\/j.diabres.2025.113001_b0195","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.pcd.2018.12.007","article-title":"Managing hypertension in people of African origin with diabetes: evaluation of adherence to NICE guidelines","volume":"3","author":"Kempegowda","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.diabres.2025.113001_b0200","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/jch.13675","article-title":"A nationwide assessment of blood pressure control and the associated factors in chinese type 2 diabetes mellitus patients","volume":"11","author":"Zhang","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.diabres.2025.113001_b0205","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2147\/JMDH.S216842","article-title":"Self-care adherence and barriers to good glycaemic control in Nepalese type 2 diabetes mellitus patients: a hospital-based cross-sectional study","author":"Pokhrel","year":"2019","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.diabres.2025.113001_b0210","first-page":"1","author":"Schmieder","year":"2018","journal-title":"Cardiovascular Diabetology"},{"key":"10.1016\/j.diabres.2025.113001_b0215","article-title":"Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: results from the longitudinal global discover study","volume":"232\u2013239","author":"Arnold","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabres.2025.113001_b0220","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12916-024-03343-w","article-title":"Assessing the impact of type 2 diabetes on mortality and life expectancy according to the number of risk factor targets achieved: an observational study","volume":"1","author":"Wang","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.diabres.2025.113001_b0225","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"9153","author":"G\u00e6de","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.113001_b0230","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"9786","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.113001_b0235","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(19)31949-X","article-title":"A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial","volume":"10205","author":"Schwalm","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.113001_b0240","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(18)30309-X","article-title":"Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial","volume":"10124","author":"McManus","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2025.113001_b0245","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2023.2854","article-title":"Coordinated care to optimize cardiovascular preventive therapies in type 2 diabetes: a randomized clinical trial","volume":"15","author":"Pagidipati","year":"2023","journal-title":"J Am Med Assoc"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:59:36Z","timestamp":1781067576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725010162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":49,"alternative-id":["S0168822725010162"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113001","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global guideline recommended target achievements in glycaemic, blood pressure, and lipid control in type 2 diabetes: An updated meta-analysis of 1,618,972 participants","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113001"}}